Cholesterol-Lowering Drugs Do Double Time

Findings presented at the 40th annual meeting of the American Society of Clinical Oncology showed that people who'd been using cholesterol-lowing drugs for at least five years, had a 47% lower chance of developing colorectal cancer.

The study involved more than 3,000 Israelis, about half of whom had colorectal cancer. The results need to be taken with a grain of salt since the study was based on questionnaires. But even with the uncertainty inherent in self-reporting, 47% seems a difficult finding to diminish.

_{Source: Peck, Peggy. Statins May Reduce Risk of Colorectal Cancer. Medscape Medical News. 9 Jun. 2004. 26 Aug. 2006 [http://www.medscape.com/viewarticle/480509].}